CORT — Corcept Therapeutics Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in Corcept Therapeutics Inc (CORT), worth $586.05M combined. Over the quarter 3 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $457.50M | 0.63% | -7.4% |
| Emerald | $65.07M | 1.50% | +264% |
| Emerald Mutual | $40.42M | 1.40% | +158.8% |
| VanEck | $12.10M | 0.00% | -12.8% |
| O'Neil | $8.55M | 1.90% | NEW |
| Quadrature | $2.41M | 0.02% | -19% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.